Results 111 to 120 of about 68,105 (186)

Clinical management of a severe skull fracture in a loggerhead sea turtle (Caretta caretta)

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract A 30.6 kg loggerhead sea turtle (Caretta caretta) presented with a 2–3‐week‐old deep head wound, left neck and right cubital lacerations, and carapace fractures. Haematology revealed a marked leukocytosis, with other values unremarkable. Initial wound‐cleaning, an antibiotic course, fluids and vitamin B supplementation were initiated. Computed
Madeline Yde   +4 more
wiley   +1 more source

Metabolic mechanism of ceftazidime resistance in Vibrio alginolyticus

open access: yes, 2019
Shi-Rao Liu,1 Xuan-Xian Peng,1,2 Hui Li1 1Center for Proteomics and Metabolomics, State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-sen University, University City,
Li H, Liu SR, Peng XX
core  

Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run

open access: yes
Background: Therapeutic drug monitoring (TDM) is becoming an increasingly recommended approach for assessing optimal pharmacokinetic/pharmacodynamic (PK/PD) target attainment of ceftazidime/avibactam.
Gatti, Milo   +2 more
core   +1 more source

Molecular markers ceftazidime treatment in vivo.

open access: yes, 2017
Molecular markers ceftazidime treatment in vivo.
Jason E. Cummings (2803606)   +1 more
core   +1 more source

Antimicrobial Resistance in Periodontal Disease: Rethinking Adjunctive Therapy in the Metagenomics Era, the Pressing Need for Precision Treatment and Periodontal Resistome Mapping

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri   +3 more
wiley   +1 more source

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

open access: yes, 2013
Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes. This review summarizes the existing data published for ceftazidime-
Hoban, Daryl J.   +11 more
core   +1 more source

Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature

open access: yes, 2019
Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological ...
Romy Rodriguez Ortega   +4 more
core   +1 more source

An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β–lactam resistance in Pseudomonas aeruginosa

open access: yesMicrobiology Spectrum
We performed a proof-of-concept study to validate a peptide-conjugated peptide nucleic acid (PPNA) directed to inhibit peptidoglycan recycling as strategy to reduce AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosa.
Maria Escobar-Salom   +7 more
doaj   +1 more source

Ceftazidime in the treatment of febrile immunosuppressed children

open access: yes, 1983
We carried out a pilot study using ceftazidime alone in the treatment of febrile, neutropenic children. A total of 16 episodes were treated before the study was re-evaluated and tobramycin was added.
Williamson, P J   +5 more
core   +1 more source

Population pharmacokinetic modeling and simulation-informed ceftazidime dosing in Chinese neonates using quantitative dried blood spot micro-sampling

open access: yesAntimicrobial Agents and Chemotherapy
Ceftazidime is widely used off-label to treat neonatal infections, underscoring the need for optimized dosing strategies. However, pharmacokinetic (PK) studies in neonates are limited by the challenges of conventional blood sampling.
Qiufen Yin   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy